Search results (372)
« Back to NewsNHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds
22 February 2023
A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.
Study supports evidence ivermectin not effective to treat COVID-19
21 February 2023
High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.
Coronavirus Vaccines Research and Development Roadmap launched
21 February 2023
Coronavirus COVID-19 General Research
The Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.
COVID-19 is a leading cause of death in children and young people in the US
31 January 2023
Coronavirus COVID-19 General Research
A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.
COVID-19 increased public trust in science, new survey shows
26 January 2023
Coronavirus COVID-19 General Research
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant
17 January 2023
Coronavirus COVID-19 General Research
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Research at the Outbreak of a Pandemic – thanking our donors
12 December 2022
A 35-page full-colour report was sent out to hundreds of donors as a thank you for their important contributions, and to show them the difference they helped to make during the pandemic.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
28 October 2022
Coronavirus COVID-19 General Research
Researchers from Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
COVID-19 continued to hit life expectancy in 2021 in unvaccinated populations and Eastern Europe
17 October 2022
Coronavirus COVID-19 General Research
COVID-19 has caused a protracted shock to life expectancy levels, leading to global mortality changes unprecedented in the last 70 years, according to research published in Nature Human Behaviour from Oxford’s Leverhulme Centre for Demographic Science and the Max Planck Institute for Demographic Research.
Gene associated with better immune response, protection after COVID-19 vaccination
13 October 2022
Researchers from the University of Oxford have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines – identifying a particular gene associated with a high antibody response.
New computational technique reveals changes to lung function post COVID-19 infection
5 October 2022
Coronavirus COVID-19 General Research
A new study led by Oxford researchers found that prior COVID-19 infection was associated with more uneven inflation of the lungs during normal breathing, smaller lung volumes, and greater respiratory dead space.
Oxford vaccine saved most lives in its first year of rollout
15 July 2022
Coronavirus COVID-19 General Research
When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Coronavirus COVID-19 General Research
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds
1 July 2022
Coronavirus COVID-19 General Research
Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.
Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination
29 June 2022
Clinical Trials Coronavirus COVID-19 General Research
The Oxford Clinical Trials Research Unit at Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) played a key role in the Vaccine Response On Off Methotrexate (VROOM) study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.
Five ways the pandemic has affected routine medical care
24 June 2022
Coronavirus COVID-19 General Research
Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
9 June 2022
Coronavirus COVID-19 General Research
People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology with the involvement of researchers from the University of Oxford.
Long COVID: vaccination could reduce symptoms, new research suggests
27 May 2022
Coronavirus COVID-19 General Research
While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.
Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds
26 May 2022
Coronavirus COVID-19 General Research
Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.
Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
24 May 2022
Coronavirus COVID-19 General Research
COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.